doi:10.3969/j.issn.1671-2587.2024.04.023

JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE ›› 2024, Vol. 26 ›› Issue (4): 570-576.DOI: 10.3969/j.issn.1671-2587.2024.04.023

Received:2024-06-26 Online:2024-08-20 Published:2024-09-23

[1] MUSZBEK L,BERECZKY Z,BAGOLY Z,et al. Factor XIII :a coagulation factor with multiple plasmatic and cellular functions[J]. Physiol Rev,2011,91(3):931-972.
[2] LAWRIE A S,GREEN L,MACKIE I J,et al. Factor XIII —an under diagnosed deficiency—are we using the right assays?[J]. J Thromb Haemost,2010,8(11):2478-2482.
[3] WATANABE H,MOKUDA S,TOKUNAGA T,et al.Expression of factor XIII originating from synovial fibroblasts and macrophages induced by interleukin-6 signaling[J]. Inflamm Regen,2023,43(1):2.
[4] SCHROEDER V,KOHLER H P. Factor XIII :structure and function[J]. Semin Thromb Hemost,2016,42(4):422-428.
[5] BYRNES J R,LEE T,SHARABY S,et al.Reciprocal stabilization of coagulation factor XIII -A and-B subunits is a determinant of plasma FXIII concentration[J]. Blood,2024,143(5):444-455.
[6] CURTIS C G,BROWN K L,CREDO R B,et al.Calcium-dependent unmasking of active center cysteine during activation of fibrin stabilizing factor[J]. Biochemistry,1974,13(18):3774-3780.
[7] KARIMI M, BERECZKY Z, COHAN N,et al. Factor XIII deficiency[J].British Journal of Haematology, 2009, 35(04):426-438.
[8] MARTA-ENGUITA J,NAVARRO-OVIEDO M,MACHADO F J D M,et al. Role of factor XIII in ischemic stroke:a key molecule promoting Thrombus stabilization and resistance to Lysis[J]. J Thromb Haemost,2024,22(4):1080-1093.
[9] DANG Y,ZHANG Y,JIAN M H,et al.Advances of blood coagulation factor XIII in bone healing[J]. Tissue Eng Part B Rev,2023,29(6):591-604.
[10] KAARTINEN M T,ARORA M,HEINONEN S,et al.F13A1 transglutaminase expression in human adipose tissue increases in acquired excess weight and associates with inflammatory status of adipocytes[J]. Int J Obes,2021,45(3):577-587.
[11] RICHARDSON V R,CORDELL P,STANDEVEN K F,et al.Substrates of factor XIII -A:roles in thrombosis and wound healing[J]. Clin Sci,2013,124(3):123-137.
[12] INBAL A,LUBETSKY A,KRAPP T,et al.Impaired wound healing in factor XIII deficient mice[J]. Thromb Haemost,2005,94(2):432-437.
[13] DARDIK R,LOSCALZO J,INBAL A. factor XIII (FXIII) and angiogenesis[J]. J Thromb Haemost,2006,4(1):19-25.
[14] ICHINOSE A. Factor XIII is a key molecule at the intersection of coagulation and fibrinolysis as well as inflammation and infection control[J]. Int J Hematol,2012,95(4):362-370.
[15] WEI Z M,GROENEVELD D J,ADELMEIJER J,et al.Coagulation factor XIII is a critical driver of liver regeneration after partial hepatectomy[J]. J Thromb Haemost,2024,22(3):620-632.
[16] ODAME J E,CHAN A K,WU J K,et al. Factor XIII deficiency management:a review of the literature[J]. Blood Coagul Fibrinolysis,2014,25(3):199-205.
[17] DORGALALEH A,NADERI M,HOSSEINI M S,et al. Factor XIII deficiency in Iran:a comprehensive review of the literature[J]. Semin Thromb Hemost,2015,41(3):323-329.
[18] KATONA É,PÉNZES K,MOLNÁR É,et al. Measurement of factor XIII activity in plasma[J]. Clin Chem Lab Med,2012,50(7):1191-1202.
[19] DORGALALEH A,NADERI M,SHAMSIZADEH M.Morbidity and mortality in a large number of Iranian patients with severe congenital factor XIII deficiency[J]. Ann Hematol,2016,95(3):451-455.
[20] MUSZBEK L,BAGOLY Z,CAIRO A,et al.Novel aspects of factor XIII deficiency[J]. Curr Opin Hematol,2011,18(5):366-372.
[21] MUSZBEK L,KATONA É.Diagnosis and management of congenital and acquired FXIII deficiencies[J]. Semin Thromb Hemost,2016,42(4):429-439.
[22] ESHGHI P,COHAN N,LAK M,et al.Arg77His and Trp187Arg are the most common mutations causing FXIII deficiency in Iran[J]. Clin Appl Thromb Hemost,2012,18(1):100-103.
[23] SHETTY S,SHELAR T,MIRGAL D,et al.Rare coagulation factor deficiencies:a countrywide screening data from India[J]. Haemophilia,2014,20(4):575-581.
[24] BISWAS A,IVASKEVICIUS V,SEITZ R,et al.An update of the mutation profile of Factor 13 A and B genes[J]. Blood Rev,2011,25(5):193-204.
[25] GHANSAH H,ORBÁN-KÁLMÁNDI R,DEBRECENI I B,et al. Low factor XIII levels and altered fibrinolysis in patients with multiple myeloma[J]. Thromb Res,2024,234:12-20.
[26] SCHROEDER V.Laboratory assessment of coagulation factor XIII [J]. Hamostaseologie,2020,40(4):467-471.
[27] DORGALALEH A,TABIBIAN S,HOSSEINI M S,et al.Diagnosis of factor XIII deficiency[J]. Hematology,2016,21(7):430-439.
[28] DORGALALEH A,TABIBIAN S,ASSADOLLAHI V,et al.Comparison of 2 methods of clot solubility testing in detection of factor XIII deficiency[J]. Lab Med,2016,47(4):283-285.
[29] ANWAR R,MILOSZEWSKI K J. Factor XIII deficiency[J].Br J Haematol,1999,107(3):468-484.
[30] FRANCIS J L.The detection and measurement of factor XIII activity:a review[J]. Med Lab Sci, 1980,37(2):137-147.
[31] DORGALALEH A,FARSHI Y,ALIZADEH S H,et al.Challenges in implementation of ISTH diagnostic algorithm for diagnosis and classification of factor XIII deficiency in Iran[J]. J Thromb Haemost, 2015,13(9):1735-1736.
[32] KOHLER H P,ICHINOSE A,SEITZ R,et al.Diagnosis and classification of factor XIII deficiencies[J]. J Thromb Haemost,2011,9(7):1404-1406.
[33] KARIMI M,PEYVANDI F,NADERI M,et al. Factor XIII deficiency diagnosis:Challenges and tools[J]. Int J Lab Hematol,2018,40(1):3-11.
[34] MUSZBEK L,POLGÁR J,FÉSÜS L. Kinetic determination of blood coagulation factor XIII in plasma[J]. Clin Chem,1985,31(1):35-40.
[35] FICKENSCHER K,AAB A,STÜBER W. A photometric assay for blood coagulation factor XIII [J]. Thromb Haemost,1991,65(5):535-540.
[36] KÁRPÁTI L,PENKE B,KATONA E,et al. A modified,optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma[J]. Clin Chem,2000,46(12):1946-1955.
[37] AJZNER E,MUSZBEK L.Kinetic spectrophotometric factor XIII activity assays:the subtraction of plasma blank is not omissible[corrected[J]. J Thromb Haemost,2004,2(11):2075-2077.
[38] DURDA M A,WOLBERG A S,KERLIN B A.State of the art in factor XIII laboratory assessment[J]. Transfus Apher Sci,2018,57(6):700-704.
[39] LIM W,MOFFAT K,HAYWARD C P M. Prophylactic and perioperative replacement therapy for acquired factor XIII deficiency[J]. J Thromb Haemost,2004,2(6):1017-1019.
[40] PARAMESWARAN K N,CHENG X F,CHEN E C,et al.Hydrolysis of gamma:Epsilon isopeptides by cytosolic transglutaminases and by coagulation factor XIII a[J]. J Biol Chem,1997,272(15):10311-10317.
[41] OERTEL K,HUNFELD A,SPECKER E,et al.A highly sensitive fluorometric assay for determination of human coagulation factor XIII in plasma[J]. Anal Biochem,2007,367(2):152-158.
[42] LEITNER M,BÜCHOLD C,PASTERNACK R,et al. Feasibility of an automated coagulation factor XIII a test using its isopeptidase activity[J]. Anal Biochem,2020,600:113757.
[43] LEITNER M,BÜCHOLD C,PASTERNACK R,et al. Clinical validation of an automated fluorogenic factor XIII activity assay based on isopeptidase activity[J]. Int J Mol Sci,2021,22(3):1002.
[44] HSU P,ZANTEK N D,MEIJER P,et al. Factor XIII Assays and associated problems for laboratory diagnosis of factor XIII deficiency:an analysis of International Proficiency testing results[J]. Semin Thromb Hemost,2014,40(2):232-238.
[45] LI B J,BILLUR R,MAURER M C,et al.Proline 36 of the factor XIII activation peptide plays a crucial role in substrate recognition and zymogen activation[J]. Thromb Haemost,2018,118(12):2037-2045.
[46] KATONA E,HARAMURA G,KÁRPÁTI L,et al. A simple,quick one-step ELISA assay for the determination of complex plasma factor XIII (A2B2)[J]. Thromb Haemost,2000,83(2):268-273.
[47] BRIDEY F,NÉGRIER C,DUVAL C,et al. Impaired factor XIII activation in patients with congenital afibrinogenemia[J].Haematologica,2019,104(3):e111-e113.
[48] DORGALALEH A,RASHIDPANAH J.Blood coagulation factor XIII and factor XIII deficiency[J].Blood Rev,2016,30(6):461-475.
[49] DORGALALEH A.The history of factor XIII deficiency[J].Semin Thromb Hemost,2024,50(1):34-42.
[50] DORGALALEH A,BAHRAINI M,SHAMS M,et al.Molecular basis of rare congenital bleeding disorders[J]. Blood Rev,2023,59:101029.
[51] DORGALALEH A,TABIBIAN S,HOSSEINI S,et al.Guidelines for laboratory diagnosis of factor XIII deficiency[J]. Blood Coagul Fibrinolysis,2016,27(4):361-364.
[52] JANG M A,PARK Y S,LEE K O,et al.Novel and recurrent mutations in the F13A1 gene in unrelated Korean patients with congenital factor XIII deficiency[J]. Blood Coagul Fibrinolysis,2015,26(1):46-49.
[53] IVASKEVICIUS V,SEITZ R,KOHLER H P,et al.International registry on factor XIII deficiency:a basis formed mostly on European data[J]. Thromb Haemost,2007,97(6):914-921.
[54] KULKARNI B P,NAIR S B,VIJAPURKAR M,et al.Molecular pathology of rare bleeding disorders (RBDs) in India:a systematic review[J]. PLoS One,2014,9(9):e108683.
[55] STANDEVEN K F,CARTER A M,GRANT P J,et al.Functional analysis of fibrin{gamma}-chain cross-linking by activated factor XIII :determination of a cross-linking pattern that maximizes clot stiffness[J]. Blood,2007,110(3):902-907.
[56] MENEGATTI M,BIGUZZI E,PEYVANDI F.Management of rare acquired bleeding disorders[J]. Hematology Am Soc Hematol Educ Program,2019,2019(1):80-87.
[57] MILLER C H,PLATT S J,RICE A S,et al.Validation of Nijmegen-Bethesda assay modifications to allow inhibitor measurement during replacement therapy and facilitate inhibitor surveillance[J]. J Thromb Haemost,2012,10(6):1055-1061.
[58] MENEGATTI M,PALLA R,BOSCARINO M,et al.Minimal factor XIII activity level to prevent major spontaneous bleeds[J]. J Thromb Haemost,2017,15(9):1728-1736.
[59] MEIJER P.Clinically needed sensitivity for very low levels of factor XIII :not yet proven for a new functional assay[J]. Clin Chem Lab Med,2011,49(10):1753-1754.
[60] SMOCK K J,MOSER K A.Automation of a factor XIII activity assay utilizing a plasma blank measurement[J]. Methods Mol Biol,2023,2663:693-706.
[61] DUVAL C,ALI M,CHAUDHRY W W,et al. Factor XIII A-subunit V34L variant affects Thrombus cross-linking in a murine model of thrombosis[J]. Arterioscler Thromb Vasc Biol,2016,36(2):308-316.
[62] TSAI M,KITA A,LEACH J,et al.In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology[J]. J Clin Invest,2012,122(1):408-418.

RichHTML

PDF

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

About

Author

Journal

Access Statistics

Contact

[1]	LIU Qing, WANG Zongkui, XU Jun, CHEN Lu, LI Changqing, DU Xi, MA Li. Biological Effects of Human Serum Albumin from Different Sources on Vascular Endothelial Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 577-586.
[2]	ZHU Xinyi, ZHANG Chengxin, WANG Qiushi, LI Jiajia, QI Yong, XIANG Dong, ZHAO Fengyong. Impact of Common Red Blood Cell Preservatives on the Dolichos Biflorus Agglutinin Binding to A₁ Phenotype Red Blood Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 587-591.
[3]	GAO Li, YANG Yiming, JIANG Xueyu, XIE Rufeng, SUN Juan, YANG Jie. The Infusion of Extracellular Vesicle Secreted by Allogeneic Tolerant Dendritic Cells Carries the Risk of Exacerbating TRALI [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 592-596.
[4]	WANG Tao, XIONG Yuqi, HUANG Yao, WANG Xiaoqing. Analysis of Activation State and Microparticle Level of Apheresis Platelets with Different Storage Time and Its Individual Differences [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 597-603.
[5]	JIANG Xueyu, YANG Yiming, SUN Juan, XIE Rufeng, GAO Li, YANG Jie. Pretreatment with Baicalin Reduces the Production of IgG and IgM in a Mouse Model of Red Blood Cell Infusion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 604-608.
[6]	SU Xiaomin, ZHANG Guoquan, Wang Jin, XU Hua. Integration of Proteomics and Metabolomics in Red Blood Cells Storage Lesion [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 609-616.
[7]	XIE Rufeng, ZHANG Jingyi, YANG Yiming, GAO Li, JIANG Xueyu, SUN Juan, YANG Jie. Enhancing the Prevention of Cold Storage-induced Lesions: An Experimental Investigation into Modulation of Platelet Reactive Oxygen Species via Low-level Near-infrared Laser Irradiation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 617-623.
[8]	WANG Jing, LUO Jinyan, ZHANG Jie, ZHANG Hanyi, ZHANG Hongwei, HUANG Yuanshuai. Preliminary Research on the Storage Damage of Extracellular Vesicles Derived from Erythrocytes to Red Blood Cells [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 624-629.
[9]	HAO Mengling, TANG Longhai, JIN Yiming, XIAO Qi, FANG Min. Analysis of Coagulation Factor Ⅷ Levels and Quality Inspection Results in Plasma Products [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 630-637.
[10]	LI Yuwei, HUANG Xia, ZHOU Yuan, LIU Ying, WANG Lin, ZOU Binbin, LIU Humin, MA Haili, XU Tingting, TANG Fei, CAO Mingjing, HOU Linghua, LI Yujun, HU Wenjia, FENG Weiping, LIU Yanyan, DUAN Yong, WEN Tao, LI Mingxia, QIU Yan. HCV Detection among Blood Donors from 18 Provincial Blood Centers in China from 2018 to 2022 [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 638-644.
[11]	QIAO Yanhui, GWI WeiPeng, XU Baohong, MUYESAIER·Yisimayili. Analysis of 249 Cases with RhD Variant Phenotypes in Xinjiang [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 645-650.
[12]	MAO Wei, JIANG Yulin, ZHU Chuanfu, YE Xin, XIE Yubin, LI Xiaofeng, LV Rong, QI Jun, FENG Zhihui, SU Xianghui, XU Yunping, TANG Longhai, XU Jing, TAN Xixi, ZHU Faming. Research on the Establishment and Application of the Genotype Database of Apheresis Platelet Donors in China [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 656-660.
[13]	FAN Chengyan, WEN Yujie, LIAN Xue, ZHANG Dan, WANG Jie, JING Yuanyuan, WANG Lijun, LI Wei, JIA Yanjun, LI Dongmei. Changes in Serum Platelet-related Antibodies in Patients with Immune Platelet Transfusion Refractoriness and Clinical Significance [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 661-666.
[14]	DENG Xuelian, ZANG Liang, LIU Xiaochun, SUN Peng, WANG Yingying, CANDOTTI Daniel, ZHOU Jun. Re-entry Strategy of Nucleic Acid Testing Reactive Blood Donors Based on HBV Infection Confirmation [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 667-674.
[15]	JIANG Xiaojie, ZHANG Jingyi, MENG Yan, HUANG Chenjia. Current Situation Analysis and Strategic Exploration for Effective and Precise Recruitment of Blood Donors among University Students [J]. JOURNAL OF CLINICAL TRANSFUSION AND LABORATORY MEDICINE, 2024, 26(5): 680-682.